home / stock / amrn / amrn news


AMRN News and Press, Amarin Corporation plc From 07/29/25

Stock Information

Company Name: Amarin Corporation plc
Stock Symbol: AMRN
Market: NASDAQ
Website: amarincorp.com

Menu

Get AMRN Alerts

News, Short Squeeze, Breakout and More Instantly...

AMRN - AMRN - Historical Price Movements Surrounding Earnings

2025-07-29 18:45:38 ET Amarin Corporation plc (AMRN) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 3.83%. The average open to low on the day of earnings was -7.07%. The average open to...

AMRN - AMRN - Historical Earnings Price Analysis

2025-07-29 18:40:40 ET Amarin Corporation plc (AMRN) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in AMRN stock price following earnings has averaged ±4.03% , with a median of 1.70%. ...

AMRN - Here are the major earnings before the open Wednesday

2025-07-29 18:00:43 ET Major earnings expected before the bell on Wednesday include: Altria Group ( MO ) The Kraft Heinz Company ( KHC ) GSK plc ( GSK ) Teva Pharmaceutical Industries Limited( TEVA ) Etsy ( ETSY ) Read the full article on Se...

AMRN - Amarin Q2 2025 Earnings Preview

2025-07-29 10:56:01 ET More on Amarin Amarin Is A Sell Despite The Large Cash Balance Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript Amarin Corporation plc 2025 Q1 - Results - Earnings Call Presentation Amarin inks licensing deal with Recordat...

AMRN - Earnings week ahead: AAPL, MSFT, AMZN, META, BA, XOM, CVX, PFE, MA, V, PYPL, SOFI, and more

2025-07-27 08:00:26 ET Earnings season hits full stride next week, with an expansive slate of reports from tech titans, energy giants, financial firms, healthcare leaders and consumer names.... Read the full article on Seeking Alpha For further details see: Earning...

AMRN - Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025

DUBLIN and BRIDGEWATER, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2025 results and recen...

AMRN - Amarin inks licensing deal with Recordati for lead drug Vazkepa

2025-06-24 07:40:11 ET More on Amarin Amarin Is A Sell Despite The Large Cash Balance Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript Amarin Corporation plc 2025 Q1 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on A...

AMRN - Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe

-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow -- -- Conference Call Today at 8:00 a.m. EDT with Investor Materials Available at AdvancingAmarin.com -- DUBLIN, Ireland ...

AMRN - Amarin Is A Sell Despite The Large Cash Balance

2025-06-06 14:46:45 ET Amarin Corporation plc ( AMRN ) is a biotech company that has long been attempting to commercialize drugs based on an active ingredient found in fish oil. Amarin's aim is to improve outcomes for people with cardiovascular disease.... Read the full ar...

AMRN - Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript

2025-05-07 11:01:18 ET Amarin Corporation plc (AMRN) Q1 2025 Earnings Conference Call May 07, 2025, 08:00 AM ET Company Participants Mark Marmur - Vice President of Corporate Communications and Investor Relations Aaron Berg - President and Chief Executive Officer ...

Previous 10 Next 10